SFA
IMNM icon

Sequoia Financial Advisors’s Immunome IMNM Stock Holding History

Sequoia Financial Advisors’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$405K Hold
19,127
– – ﹤0.01% 1471
2026
Q1 		$418K Hold
19,127
– – ﹤0.01% 1378
2025
Q4 		$411K Buy
19,127
+56
+0.3% +$983 ﹤0.01% 1387
2025
Q3 		$223K Buy
19,071
+6
+0% +$60 ﹤0.01% 1574
2025
Q2 		$177K Hold
19,065
– – ﹤0.01% 1493
2025
Q1 		$128K Hold
19,065
– – ﹤0.01% 1310
2024
Q4 		$202K Buy
19,065
+2,000
+12% +$24.2K ﹤0.01% 1220
2024
Q3 		$249K Hold
17,065
– – ﹤0.01% 1059
2024
Q2 		$206K Buy
+17,065
New +$267K ﹤0.01% 1096

Other funds holding IMNM

TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
SI
Scharf Investments Los Gatos, California $3.03B AUM 7.75% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

Sequoia Financial Advisors's IMNM Position: Q2 2026 in Review

Sequoia Financial Advisors held its Immunome (IMNM) position steady in Q2 2026 at 19,127 shares worth $405K. The position accounts for ﹤0.01% of the portfolio, ranked #1471.

Sequoia Financial Advisors first reported a position in IMNM in Q2 2024 and has held it in 9 quarters since. The position peaked at $418K in Q1 2026. 7 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Sequoia Financial Advisors held 19,127 shares of Immunome worth $405K as of Q2 2026.
  • Sequoia Financial Advisors left its Immunome share count unchanged in Q2 2026.
  • Immunome made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #1471 holding.
  • Sequoia Financial Advisors first reported a position in Immunome in Q2 2024 and has held it in 9 quarters since.
  • Sequoia Financial Advisors's Immunome position peaked at $418K in Q1 2026.
  • 7 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.